Matches in SemOpenAlex for { <https://semopenalex.org/work/W3020744031> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W3020744031 endingPage "1175" @default.
- W3020744031 startingPage "1167" @default.
- W3020744031 abstract "Objective: To compare relapse rates and healthcare costs in MS patients treated with Glatopa 20 mg (generic glatiramer acetate) versus Copaxone 20 mg in a US managed care population.Methods: A retrospective claims study was conducted using the HealthCore Integrated Research Database. Patients with ≥1 Glatopa or Copaxone claim between 01 April 2015 (Glatopa) or 01 January 2013 (Copaxone) and 30 April 2018 were included. Patients with prior Copaxone 40 mg use or <1 year continuous health plan enrollment were excluded. Patients who switched from Glatopa to Copaxone were censored. Glatopa users were matched to Copaxone users, and outcomes measured at 6–12 months follow-up.Results: A total of 357 Glatopa and 2291 Copaxone patients qualified for inclusion; 158 per cohort were retained after matching. Baseline characteristics were well-balanced (mean age 49.9 years, 75% female, mean 3.8 Copaxone fills). At baseline, 8% of patients had ≥1 relapse with mean annualized relapse rates (ARR) of 0.18; at follow-up, the relapse rates were 8% versus 15% (Glatopa versus Copaxone; p = .05), and ARRs were 0.12 versus 0.30 (p = .05). 45% of Glatopa patients switched (back) to Copaxone 20/40 mg and were censored at that point. Mean (SD) all-cause medical and pharmacy costs were $51,507 ($28,494) versus $55,085 ($37,061; p = .50). Mean MS-related costs were $45,379 ($24,732) versus $47,949 ($32,615; p = .67), of which mean disease modifying therapy costs were $42,926 ($23,196) versus $44,932 ($28,554; p = .59). Results were similar in sensitivity analyses.Conclusions: In this real-world study, MS patients treated with Glatopa experienced similar health outcomes and costs compared to those treated with Copaxone, with a trend towards lower relapse rates (borderline statistically significant) and cost savings (not statistically significant)." @default.
- W3020744031 created "2020-05-01" @default.
- W3020744031 creator A5000669492 @default.
- W3020744031 creator A5005017303 @default.
- W3020744031 creator A5019554240 @default.
- W3020744031 creator A5054870186 @default.
- W3020744031 creator A5074999356 @default.
- W3020744031 creator A5090788600 @default.
- W3020744031 date "2020-05-13" @default.
- W3020744031 modified "2023-10-16" @default.
- W3020744031 title "Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate" @default.
- W3020744031 cites W1490014604 @default.
- W3020744031 cites W1975165564 @default.
- W3020744031 cites W2006978204 @default.
- W3020744031 cites W2014094373 @default.
- W3020744031 cites W2127809083 @default.
- W3020744031 cites W2155163959 @default.
- W3020744031 cites W2159411766 @default.
- W3020744031 cites W2195384937 @default.
- W3020744031 cites W2209512939 @default.
- W3020744031 cites W2329332344 @default.
- W3020744031 cites W2471246819 @default.
- W3020744031 cites W2600313485 @default.
- W3020744031 cites W2795882173 @default.
- W3020744031 cites W2894033169 @default.
- W3020744031 cites W2896073250 @default.
- W3020744031 doi "https://doi.org/10.1080/03007995.2020.1760808" @default.
- W3020744031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32329362" @default.
- W3020744031 hasPublicationYear "2020" @default.
- W3020744031 type Work @default.
- W3020744031 sameAs 3020744031 @default.
- W3020744031 citedByCount "1" @default.
- W3020744031 countsByYear W30207440312023 @default.
- W3020744031 crossrefType "journal-article" @default.
- W3020744031 hasAuthorship W3020744031A5000669492 @default.
- W3020744031 hasAuthorship W3020744031A5005017303 @default.
- W3020744031 hasAuthorship W3020744031A5019554240 @default.
- W3020744031 hasAuthorship W3020744031A5054870186 @default.
- W3020744031 hasAuthorship W3020744031A5074999356 @default.
- W3020744031 hasAuthorship W3020744031A5090788600 @default.
- W3020744031 hasConcept C104863432 @default.
- W3020744031 hasConcept C126322002 @default.
- W3020744031 hasConcept C160735492 @default.
- W3020744031 hasConcept C162324750 @default.
- W3020744031 hasConcept C1862650 @default.
- W3020744031 hasConcept C187212893 @default.
- W3020744031 hasConcept C203014093 @default.
- W3020744031 hasConcept C2778577042 @default.
- W3020744031 hasConcept C2779134260 @default.
- W3020744031 hasConcept C2780265253 @default.
- W3020744031 hasConcept C2780640218 @default.
- W3020744031 hasConcept C2908647359 @default.
- W3020744031 hasConcept C2992755240 @default.
- W3020744031 hasConcept C50522688 @default.
- W3020744031 hasConcept C512399662 @default.
- W3020744031 hasConcept C71924100 @default.
- W3020744031 hasConcept C72563966 @default.
- W3020744031 hasConcept C99454951 @default.
- W3020744031 hasConceptScore W3020744031C104863432 @default.
- W3020744031 hasConceptScore W3020744031C126322002 @default.
- W3020744031 hasConceptScore W3020744031C160735492 @default.
- W3020744031 hasConceptScore W3020744031C162324750 @default.
- W3020744031 hasConceptScore W3020744031C1862650 @default.
- W3020744031 hasConceptScore W3020744031C187212893 @default.
- W3020744031 hasConceptScore W3020744031C203014093 @default.
- W3020744031 hasConceptScore W3020744031C2778577042 @default.
- W3020744031 hasConceptScore W3020744031C2779134260 @default.
- W3020744031 hasConceptScore W3020744031C2780265253 @default.
- W3020744031 hasConceptScore W3020744031C2780640218 @default.
- W3020744031 hasConceptScore W3020744031C2908647359 @default.
- W3020744031 hasConceptScore W3020744031C2992755240 @default.
- W3020744031 hasConceptScore W3020744031C50522688 @default.
- W3020744031 hasConceptScore W3020744031C512399662 @default.
- W3020744031 hasConceptScore W3020744031C71924100 @default.
- W3020744031 hasConceptScore W3020744031C72563966 @default.
- W3020744031 hasConceptScore W3020744031C99454951 @default.
- W3020744031 hasIssue "7" @default.
- W3020744031 hasLocation W30207440311 @default.
- W3020744031 hasOpenAccess W3020744031 @default.
- W3020744031 hasPrimaryLocation W30207440311 @default.
- W3020744031 hasRelatedWork W1969696638 @default.
- W3020744031 hasRelatedWork W2003556049 @default.
- W3020744031 hasRelatedWork W2168630024 @default.
- W3020744031 hasRelatedWork W2396047537 @default.
- W3020744031 hasRelatedWork W2775342387 @default.
- W3020744031 hasRelatedWork W3020744031 @default.
- W3020744031 hasRelatedWork W4250592434 @default.
- W3020744031 hasRelatedWork W4300704595 @default.
- W3020744031 hasRelatedWork W4301303616 @default.
- W3020744031 hasRelatedWork W6143703 @default.
- W3020744031 hasVolume "36" @default.
- W3020744031 isParatext "false" @default.
- W3020744031 isRetracted "false" @default.
- W3020744031 magId "3020744031" @default.
- W3020744031 workType "article" @default.